TXMD TherapeuticsMD, Inc.: institutional ownership and insider trading
49 funds reported holding $9.81M of TherapeuticsMD, Inc. in their latest 13F filings; in Q2 2026 funds net sold $614K, with 4 new positions and 7 funds selling out; over the last 12 months insiders bought $14.0K and sold $0 on the open market.
Famous investors holding TXMD
- Renaissance Technologies (Renaissance Technologies): $324K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $190K, 0.0% of the portfolio
Largest institutional holders of TXMD
- Rubric Capital Management LP — $2.63M
- Clearline Capital LP — $1.40M
- Banque Cantonale Vaudoise — $1.00M
- VANGUARD CAPITAL MANAGEMENT LLC — $782K
- Tejara Capital Ltd — $761K
- ADAR1 Capital Management, LLC — $757K
- VANGUARD GROUP INC — $647K
- RENAISSANCE TECHNOLOGIES LLC — $324K
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $286K
- BlackRock, Inc. (BLK) — $254K
Recent TXMD insider trades
- Dec 23, 2025: Thompson Tommy G bought 8,400 shares ($14.0K)
- Apr 14, 2025: Thompson Tommy G bought 325 shares ($325)
- Apr 14, 2025: Walker Marlan D bought 490 shares ($490)
- Apr 10, 2025: Walker Marlan D bought 2,303 shares ($1.99K)
5%+ owners
- Baselake Partners, LP: 6.8% (Schedule 13G/A, filed Aug 5, 2026)